The SPRINTT results will thus have relevant clinical and public health implications, filling an important gap in knowledge for practicing evidence-based geriatric medicine. The ultimate goals of SPRINTT are indeed to offer efficient treatment options to older persons with PF&S and to increase their quality of life. This approach may be quickly scaled up in general medical practice across European countries.



